Abstract:Background and aim of the study: The study aim was to evaluate the effect of percutaneous balloon mitral valvuloplasty (PBMV) on plasma B-type natriuretic peptide (BNP) levels in patients in sinus rhythm (SR) and with atrial fibrillation (AF).Methods: Thirty patients with rheumatic mitral stenosis who underwent successful PBMV were included in the study. Of these patents, 21 were in SR (SR group) and nine had AF (AF group). Plasma BNP levels were measured using the Triage BNP Test in all patients before, and at 20 min and 24 h after, PBMV. Control levels were measured in eight healthy volunteers.Results: Basal plasma BNP levels in patients were significantly higher than those in controls (123.5 +/- 69.5 versus 16.4 +/- 7.6 pg/ml, p < 0.01), and correlated with mean left atrial pressure (mLAP; r = 0.441, p < 0.05) and pulmonary artery pressure (PAP; r = 0.488, p < 0.01). No significant difference was observed in BNP levels between the SR and AF groups. In the SR group, BNP levels decreased after PBMV (pre-PBMV 128.7 +/- 75.9 pg/ml; at 20 min, 88.6 +/- 62.0 pg/ml; at 24 h, 43.4 +/- 26.7 pg/ml; respectively, p < 0.05). Changes in plasma BNP (Delta BNP) correlated positively with those in mLAP (Delta mLAP) (r = 0.696, p < 0.01) and PAP (APAP) (r = 0.456, p < 0.05). Left ventricular end-diastolic volume (LVEDV) (96.1 +/- 21.6 versus 111.5 +/- 25.2 ml, p < 0.01) and stroke volume (SV) (59.2 +/- 15.8 versus 69.0 +/- 17.9 ml, p < 0.05) augmented accordingly without any changes in left ventricular end-diastolic pressure (LVEDP) (p = NS). In contrast, in group AF, BNP levels remained unchanged (pre-PBMV 111.6 +/- 53.4 pg/ml; at 20 min, 122.0 +/- 68.7 pg/ml; at 24 h, 106.1 +/- 56.2 pg/ml; respectively, p NS), while LVEDP increased (6.4 +/- 3.6 versus 8.6 +/- 3.2 mmHg, p < 0.01), without any changes in LVEDV and SV (p = NS).Conclusion: The study results indicate that, in mitral stenosis patients, a high BNP level is associated with high mLAP and PAP. Cardiac rhythm may play an important role in changes of BNP level after PBMV. BNP may be a valid marker to reflect changes in mLAP and PAP after PBMV in patients with SR, but not in those with AF.

Clinical Effect of Percutaneous Balloon Mitral Valvuloplasty in Treatment of Rheumatic Mitral Stenosis

Clinical application of percutaneous balloon mitral valvuloplasty in patients with rheumatic mitral stenosis and left atrial thrombi

Effects of Percutaneous Balloon Mitral Valvuloplasty on Plasma B-type Natriuretic Peptide in Rheumatic Mitral Stenosis with and Without Atrial Fibrillation.

Effects of Percutaneous Balloon Mitrai Valvuloplasty on Plasma B-type Natriuretic Peptide in Rheumatic Mitral Stenosis Patients

Short Term and Long-Term Results of Percutaneous Balloon Mitral Valvuloplasty in Patients with Mitral Stenosis and Atrial Fibrillation

Evaluation on Results of Repeat Percutaneous Balloon Mitral Valvuloplasty for Mitral Restenosis Following Prior Balloon Valvuloplasty

Percutaneous Balloon Mitral Valvotomy for Mitral Stenosis with Moderate to Severe Pulmonary Hypertension

Changes of Plasma B-type Natriuretic Peptide after Percutanouse Balloon Mitral Valvuloplasty

One-step Method for Percutaneous Balloon Mitral Valvuloplasty in the Senile and Pre-Senile Patients with Mitral Stenosis

[Percutaneous Balloon Aortic Valvuloplasty for Congenital Valvular Aortic Stenosis in Children].

Percutaneous balloon mitral valvuloplasy in patients with atrial fibrilation and left atrial thrombus

Assessment of function on left atrial and biventricular in patients with rheumatic mitral stenosis before and after percutaneous mitral balloon valvuloplasty by real-time three-dimensional echocardiography

Systematic Comparison of the Effectiveness of Percutaneous Mitral Balloon Valvotomy with Surgical Mitral Commissurotomy

Transseptal Methods for Percutaneous Balloon Valvoplasty Simultaneously with Radiofrequency Catheter Ablation

Revisiting percutaneous balloon mitral valvotomy technique and safety in various population: an evidence-based case report and literature review

Percutaneous balloon mitral valvuloplasty using veno‐arterial loop and neuro‐embolic protection for mitral stenosis with thrombus

A clinical analysis of percutaneous balloon pulmonary valvuloplasty with inoue-balloon for pulmonary valve stenosis in adults

Incidence and predictors of adverse outcomes in patients with rheumatic mitral stenosis following percutaneous balloon mitral valvuloplasty: a study from a tertiary center in Thailand

Mitral stenosis: evaluation with MR imaging after percutaneous balloon valvuloplasty.

The Prevention and Management of Complications During and Immediately after Percutaneous Balloon Mitral Valvuloplasty

Influence of Right Atrial Pressure on the Prognosis of Patients with Rheumatic Mitral Stenosis Undergoing Percutaneous Mitral Balloon Valvuloplasty